Lexicon Pharmaceuticals, Inc. LXRX

1.80 (0.06) (3.23%) as of 25 Sep
Market cap
$854.3M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
96.23 237.96 170.03 138.36 86.74 152.28 271.66 160.05 310.79 346.50
Receivables
2.38 3.47 1.01 0.03 0.01 0.40 56.53 5.92 4.83 7.49
Inventory
0.28 0.23 0.38 — — 0.35 4.24 4.68 1.95 —
Total current assets
101.90 246.19 176.55 140.87 88.92 157.72 337.75 173.32 322.00 357.87
Property, Plant, Equpment (Net)
1.86 2.48 1.99 2.07 1.18 0.30 14.05 15.87 17.69 19.39
Goodwill and Intangible Assets (Total)
44.54 44.54 44.54 44.54 44.54 44.54 64.26 94.66 96.43 97.90
Long-term assets (Other)
29.37 0.37 0.83 0.41 2.27 1.23 1.66 0.29 0.43 0.46
Total non-current assets
83.09 52.23 52.88 53.43 47.99 46.07 79.96 110.81 114.54 117.75
Total Assets
184.99 298.42 229.43 194.30 136.91 203.79 417.72 284.14 436.54 475.63
Accounts Payable
3.08 14.80 14.39 10.40 9.15 5.47 12.18 12.05 38.76 52.88
Accrued Expenses
13.19 30.45 17.16 12.78 12.97 29.69 42.15 21.25 12.28 32.11
Current Part of Debt
4.60 — — 1.29 1.09 11.65 11.01 1.12 14.09 16.28
Current Revenue (Deferred)
— — — — — — — 2.34 40.35 63.37
Total current liabilities
20.87 45.25 31.55 23.17 22.12 46.81 65.34 36.75 105.49 164.64
Long Term Debt (Total)
49.41 100.30 99.51 48.58 1.19 0.61 234.17 243.89 231.58 85.17
Non-current Revenue (Deferred)
— — — — — — — 23.65 24.90 48.93
Long Term Tax Liability (Deferred)
— — — — — — (6.01) 6.01 6.01 18.68
Non-current Liabilities (Other)
7.17 6.92 5.27 — 1.19 0.61 1.10 0.24 0.29 0.81
Total non-current liabilities
56.58 107.22 104.77 54.00 1.19 0.61 235.27 273.79 262.79 153.58
Total liabilities
77.45 152.47 136.32 77.18 23.31 47.42 300.61 310.54 368.27 318.22
Additional Paid In Capital
2,129.91 2,117.33 1,862.56 1,709.14 1,608.75 1,561.10 1,462.17 1,447.95 1,435.53 1,411.22
Common Stock (Net)
0.37 0.36 0.25 0.19 0.15 0.14 0.11 0.11 0.11 0.11
Retained Earnings
(2,017.58) (1,967.24) (1,766.84) (1,589.72) (1,487.78) (1,400.02) (1,341.44) (1,471.58) (1,365.24) (1,250.36)
Treasury Stock
5.19 4.62 2.89 2.06 7.52 4.84 3.82 2.88 1.90 3.37
Common Equity (Total)
107.54 145.95 93.11 117.12 113.60 156.37 117.10 (26.41) 68.27 157.40
Shareholders Equity (Total)
107.54 145.95 93.11 117.12 113.60 156.37 117.10 (26.40) 68.27 157.40
Shareholders Equity and Liabilities (Total)
184.99 298.42 229.43 194.30 136.91 203.79 417.72 284.14 436.54 475.63
Shares (Common)
363.47 361.49 244.93 188.73 148.92 141.50 106.27 105.93 105.59 104.28
Shareholders Equity (Tangible)
63.00 101.41 48.57 72.58 69.05 111.83 52.84 (121.07) (28.16) 59.50
Net Debt
(42.23) (137.66) (70.52) (88.49) (84.46) (140.02) (26.48) 84.95 (65.12) (245.06)
Total Debt
54.00 100.30 99.51 49.87 2.28 12.26 245.18 245.00 245.67 101.45

Fold the line items

In millions of $ except per-share values · columns are period end dates